Evidence map›Paper›PMID 31750842›Full record

ReviewNatural product reports2020

Biologically active marine natural products and their molecular targets discovered using a chemical genetics approach.

David E Williams, Raymond J Andersen

Abstract readReview
In one paragraph

Review in Natural product reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Marine Natural Products as Novel Treatments for Parasitic Diseases.Handbook of experimental pharmacology · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Total synthesis of nahuoic acid AChemical science · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David E WilliamsDepartments of Chemistry and Earth, Ocean & Atmospheric Science, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada. raymond.andersen@ubc.ca.
Raymond J Andersen

Funding

Novel compounds that inhibit transactivation of N-terminal domain of the androgenR01CA105304 · NCI · PROVINCIAL HEALTH SERVICES AUTHORITY · PI SADAR, MARIANNE D · 2004 to 2021
$3.7M
CIHRNCI NIH HHS R01 CA105304
6 · The paper itself

Abstract

Covering: 2000 to 2019The discovery of new natural products that have some combination of unprecedented chemical structures, biological activities of therapeutic interest for urgent medical needs, and new molecular targets provides the fuel that sustains the vitality of natural products chemistry research. Unfortunately, finding these important new compounds is neither routine or trivial and a major challenge is finding effective discovery paradigms. This review presents examples that illustrate the effectiveness of a chemical genetics approach to marine natural product (MNP) discovery that intertwines compound discovery, molecular target identification, and phenotypic response/biological activity. The examples include MNPs that have complex unprecedented structures, new or understudied molecular targets, and potent biological activities of therapeutic interest. A variety of methods to identify molecular targets are also featured.

Indexed as

AnimalsAquatic OrganismsBiological ProductsDrug DiscoveryGlycoside Hydrolase InhibitorsHistone-Lysine N-MethyltransferaseHumansMethicillin-Resistant Staphylococcus aureusPhenotypePhosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesBiological ProductsGlycoside Hydrolase InhibitorsHistone-Lysine N-MethyltransferaseKMT5A protein, humanPhosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases

Identifiers

PMID31750842
PMCPMC7874888

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.